Spencer Trask Revenue and Competitors
Estimated Revenue & Valuation
- Spencer Trask's estimated annual revenue is currently $15M per year.
- Spencer Trask's estimated revenue per employee is $333,333
Employee Data
- Spencer Trask has 45 Employees.
- Spencer Trask grew their employee count by 0% last year.
Spencer Trask's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO Spencer Trask Media & Communications Group, LLC | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Managing Director Business Recovery | Reveal Email/Phone |
5 | Controller | Reveal Email/Phone |
Spencer Trask Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 32 | 14% | N/A | N/A |
#2 | $7.5M | 37 | 6% | N/A | N/A |
#3 | $7.5M | 18 | -5% | N/A | N/A |
#4 | $1.7M | 26 | 0% | N/A | N/A |
#5 | $35M | 401 | 10% | N/A | N/A |
#6 | $15M | 98 | 11% | $6.2B | N/A |
#7 | $7.5M | 49 | 7% | N/A | N/A |
#8 | $15M | 192 | 24% | N/A | N/A |
#9 | $750M | 48 | 14% | $825M | N/A |
#10 | $1.7M | 4 | -50% | N/A | N/A |
What Is Spencer Trask?
Spencer Trask transforms innovative ideas into world-changing companies. Our network of private investors and business leaders supports the dreams of scientists, inventors and entrepreneurs. We stand behind obsessive missionaries—people with visionary ideas and ground-breaking technologies that help people. Our network has provided financial and intellectual capital for some of the most influential ventures in technology and healthcare including Myriad Genetics, Ciena, Osiris Therapeutics, and Health Dialog.
keywords:N/AN/A
Total Funding
45
Number of Employees
$15M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.1M | 45 | 7% | N/A |
#2 | $11.9M | 46 | 5% | N/A |
#3 | $7.9M | 47 | -2% | N/A |
#4 | $8.1M | 48 | 0% | N/A |
#5 | $7.5M | 49 | 7% | N/A |